Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
Blood Advances
|
May 27, 2025
American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients
Paul Monagle, Muayad Azzam, Rachel Bercovitz, et al.
Blood Advances
|
December 22, 2020
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)
Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, et al.
Journal of the American College of Cardiology
|
December 6, 2023
Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease
R Mark Payne, Kristin M Burns, Andrew C Glatz, et al.
Blood Advances
|
April 8, 2026
ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous Thromboembolism
Marisol Betensky, Muayad Azzam, Rachel Sara Bercovitz, et al.
The Lancet. Haematology
|
November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
Christoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
Blood Advances
|
June 25, 2025
Efficacy and Safety of Thrombolysis for Pediatric Venous Thromboembolism: A Systematic Review and Meta-analysis
Hassan Kawtharany, Muayad Azzam, Aseel Alkhader, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 6, 2024
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal
Manuela Albisetti, Jesús Ardila, Jan Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 9, 2024
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
Mark W Skinner, Manuela Albisetti, Jesús Ardila, et al.
The New England Journal of Medicine
|
May 26, 2016
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
Flora Peyvandi, Pier M Mannucci, Isabella Garagiola, et al.
Blood
|
August 9, 2013
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Corien L Eckhardt, Alice S van Velzen, Marjolein Peters, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
Blood Advances
|
May 27, 2025
American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients
Paul Monagle, Muayad Azzam, Rachel Bercovitz, et al.
Blood Advances
|
December 22, 2020
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)
Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, et al.
Journal of the American College of Cardiology
|
December 6, 2023
Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease
R Mark Payne, Kristin M Burns, Andrew C Glatz, et al.
Blood Advances
|
April 8, 2026
ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous Thromboembolism
Marisol Betensky, Muayad Azzam, Rachel Sara Bercovitz, et al.
The Lancet. Haematology
|
November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
Christoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
Blood Advances
|
June 25, 2025
Efficacy and Safety of Thrombolysis for Pediatric Venous Thromboembolism: A Systematic Review and Meta-analysis
Hassan Kawtharany, Muayad Azzam, Aseel Alkhader, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 6, 2024
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal
Manuela Albisetti, Jesús Ardila, Jan Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 9, 2024
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
Mark W Skinner, Manuela Albisetti, Jesús Ardila, et al.
The New England Journal of Medicine
|
May 26, 2016
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
Flora Peyvandi, Pier M Mannucci, Isabella Garagiola, et al.
Blood
|
August 9, 2013
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Corien L Eckhardt, Alice S van Velzen, Marjolein Peters, et al.
Page
of 15